Retatrutide (LY3437943) is a novel triple agonist peptide that targets the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors simultaneously. This multi-receptor engagement profile makes it a compelling compound for metabolic research, with studies investigating its effects on energy balance, lipid metabolism, and glycemic regulation. Each batch is manufactured under rigorous quality controls and independently verified for purity by third-party analytical testing.
For Research Use Only. This product is not intended for human or veterinary use, diagnostic, or therapeutic purposes. It must not be used as a food, drug, or cosmetic. By adding to cart you confirm you are a qualified researcher using this product in compliance with all applicable laws.
Secure checkout with Cash App, Zelle, or Bitcoin.
All products for research use only.